AtaiBeckley (ATAI) EBITDA Margin Growth (3y) (2024 - 2025)

AtaiBeckley (ATAI) EBITDA Margin Growth (3y) (2024 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin Growth (3y) (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	9,942.00
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	530.00
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-1,211.00
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-623.00
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	AtaiBeckley	2.56 Bn	2.56 Bn	-	15.63 Mn

Download Data